RT Journal Article SR Electronic T1 Finding useful biomarkers for Parkinson’s disease JF Science Translational Medicine FD American Association for the Advancement of Science SP eaam6003 DO 10.1126/scitranslmed.aam6003 VO 10 IS 454 A1 Chen-Plotkin, Alice S. A1 Albin, Roger A1 Alcalay, Roy A1 Babcock, Debra A1 Bajaj, Vikram A1 Bowman, Dubois A1 Buko, Alex A1 Cedarbaum, Jesse A1 Chelsky, Daniel A1 Cookson, Mark R. A1 Dawson, Ted M. A1 Dewey, Richard A1 Foroud, Tatiana A1 Frasier, Mark A1 German, Dwight A1 Gwinn, Katrina A1 Huang, Xuemei A1 Kopil, Catherine A1 Kremer, Thomas A1 Lasch, Shirley A1 Marek, Ken A1 Marto, Jarrod A. A1 Merchant, Kalpana A1 Mollenhauer, Brit A1 Naito, Anna A1 Potashkin, Judith A1 Reimer, Alyssa A1 Rosenthal, Liana S. A1 Saunders-Pullman, Rachel A1 Scherzer, Clemens R. A1 Sherer, Todd A1 Singleton, Andrew A1 Sutherland, Margaret A1 Thiele, Ines A1 van der Brug, Marcel A1 Van Keuren-Jensen, Kendall A1 Vaillancourt, David A1 Walt, David A1 West, Andrew A1 Zhang, Jing YR 2018 UL http://stm.sciencemag.org/content/10/454/eaam6003.abstract AB The recent advent of an “ecosystem” of shared biofluid sample biorepositories and data sets will focus biomarker efforts in Parkinson’s disease, boosting the therapeutic development pipeline and enabling translation with real-world impact.